Recent Posts
-
Sotyktu floundering
word on the Street is that we will announce our biggest "clinical buy" yet, over $100 million and we will report total quarterly sales of $225 million, well on the way to flop buster status. It will be eerily silent on the 40% share.
-
-
Novartis announced its new leader
Basel would not have allowed him to sell Otezla and keep our turdtkytu, you can be sure.
-
-
-
Biogen: Don’t expect any big acquisitions this year
via While the company is eager to diversify beyond neuroscience, CEO Chris Viehbacher said that in the near-term any dealmaking would likely focus on collaborations and early-stage assets. article source
- + Show More
-
General Discussion
Discussion boards of general interest for those in the pharma, biotech, medical device, and related industries
-
Pharma/Biotech Companies
Anonymous discussion boards for pharmaceutical and biotech companies
-
Regional Discussion and Job Opportunities
Discussion and job opportunities by region
-
Lost Civilizations
Anonymous discussion boards for pharma/medical companies that no longer exist due to acquisition or other factors
-
Laboratory/Diagnostic Sales
Anonymous discussion boards for lab sales/diagnostics companies
-
Animal Health Sales
Anonymous discussion boards for animal health companies
-
Medical Equipment/Device Sales
Anonymous discussion boards for medical equipment/device companies
-
Pharmacies
Anonymous boards for pharmacy employees
-
PBMs
Anonymous discussion boards for PBMs
-
Pharma/Healthcare Marketing Agencies
Anonymous discussion boards for pharma/healthcare marketing agencies
-
Dental Reps
Anonymous discussion boards for dental health companies
-
Managed Care Specialists
Anonymous discussion boards for managed care specialists
-
Pharma IT
Anonymous discussion boards for pharma IT employees